Latest news
Loading news…
4D Molecular Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Emeryville, California, United States Founded 2013 101-250 employees For Profit
4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
4D Molecular Therapeutics on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Total Funding
$899.49M
Funding Rounds
8
Last Funding
Acquisitions
0
Monthly Visits
Contacts
154
Ticker
FDMT
NASDAQ
Patents
36
4 trademarks
About 4D Molecular Therapeutics
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Public
- Ticker
- FDMT
- Exchange
- NASDAQ
- IPO date
- Dec 10, 2020
- Raised at IPO
- $193.2M
- Valuation at IPO
- $580.29M
- Valuation range
- $500M to $1B
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 3
- Active products
- 27
- Patents granted
- 36
- Trademarks
- 4
- Top patent class
- Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering
- IT spend
- $2.6K
Company Info
- Founded
- 2013
- Employees
- 101-250
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 3
- News articles
- 201
- HQ
- Emeryville, California, United States
- Region
- San Francisco Bay Area, West Coast, Western US
- Diversity spotlight
- Women Founded
- Exit date
- Dec 10, 2020
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -0.3
- Trend (30d)
- 7.8
- Trend (90d)
- 7.8
- Last leadership hire
- Jan 1, 2026
4D Molecular Therapeutics Funding Rounds
8 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–5 of 8Show
Page 1 / 2
4D Molecular Therapeutics Key People
Executive Chairman
Co-Founder & CEO
Chief Medical Officer
SVP of Biometrics and Data Quality
Chief Of Staff
154
professional contacts at 4D Molecular Therapeutics
Contact execs at 4D Molecular Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to 4D Molecular Therapeutics
Loading news…
FAQs about 4D Molecular Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.